29 Infos zu Bjoern Hock

1 Aktuelle Nachrichten

... R&D workflow platform,” said Dr. Bjoern Hock, Director, Global Head Protein Engineering and Antibody Technologies at Merck Serono.

5 Profile in Sozialen Netzwerken

Bjoern Hocks berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Bjoern Hock dabei hilft, ... Es fehlt: éditions ‎magellan

Bjoern Hock. Founder and CEO, Lavaux Biotech consulting; CDO Tubulis GmbH. Lavaux Biotech Consulting SARL Technische Universität Darmstadt ...

Biotech expert with track record in bringing biothe…utics form idea to clinical development. | Learn more about Bjoern M Hock's work experience, ...

› people

3 Hobbys & Interessen

Recent bibliographic sampling of Bjoern HOCK patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):

Bjoern Hock, Director, Global Head Protein Engineering and Antibody Technologies at Merck Serono. “The platform will help to increase Merck ...

1 Business-Profile

MERCK PATENT GMBH, Maintal, DE

1 Persönliche Webseiten

Click to get Bjoern Hock's Role: VP Biologics Technologies and Development @ Ferring …s, Frankfurt Am Main Area, Germany.

1 Besitz

This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....

1 Bücher zum Namen

Birgit Piater, Achim Doerner, Ralf Guenther, and Bjoern Hock are employees of the company Merck-Serono, Merck KGaA Darmstadt. This does ...

1 Wissenschaftliche Publikationen

Kristina Hedfalk. Sweden. Elmar Heinzle. Germany. Peter Henderson. United Kingdom. Colin Hill. Ireland. Krzysztof Hinc. Poland. Bjoern Hock.

1 Video- & Audioinhalte

Teile deine Videos mit Freunden, Verwandten oder der ganzen Welt

1 Meinungen & Artikel

Bjoern Hock, Director, Global Head of Protein Engineering & Antibody Technologies, Merck Serono Krzysztof Masternak, Head of Biology, NovImmune

12 Webfunde aus dem Netz

View Bjoern Hock's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Bjoern Hock discover inside ...

We are excited to announce that Bjoern Hock, PhD, will support Tubulis as Chief Development Officer! Björn is a seasoned industry expert with 20+ years of ...

Inventor: Ralf Guenther: Bjoern Hock: Simon Goodman: Birgit Piater; Current Assignee. The listed assignees may be inaccurate. › patents

How to say Bjoern Hock in English? Pronunciation of Bjoern Hock with 1 audio pronunciation and more for Bjoern Hock.

posted on , 00:08 by Birgit Piater, Achim Doerner, Ralf Guenther, Harald Kolmar, Bjoern Hock. The human receptor tyrosine kinase c-Met plays an ... › articles › dataset ›

includes Aptamers Binding to c-Met Inhibiting Tumor Cell Migrati by Birgit Piater, Achim Doerner, Ralf Guen. Click to explore.

posted on by Birgit Piater, Achim Doerner, Ralf Guenther, Harald Kolmar, Bjoern Hock. (A, B) A549 cells or (C) EBC-1 cells were serum-starved and ...

Bjoern Hock, Maintal DE ; , BISPECIFIC APTAMERS MEDIATING TUMOUR CELL LYSIS - Disclosed are bispecific aptamers binding with high specifity to a ... › ...

Bjoern Hock, Ph.D. Director, Global Head Protein Engineering and Antibody Technologies. Previous Next. Predicted solubility data are conveniently displayed ... › ...

Birgit Piater, Achim Doerner, Ralf Guenther, Harald Kolmar, Bjoern Hock and Vittorio de Franciscis. PLoS ONE, 2015, 10, e DOI: journal. pone.

Seng Beng Ho, SG, Singapore, NOVEL BOOK-LIKE INTERNET BROWSER FOR ELECTRONIC INFORMATION, 2. Hung Hui Ho, TW, Hsinchu Bjoern Hock, DE, Maintal, BISPECIFIC APTAMERS MEDIATING TUMOUR CELL LYSIS, 7. Christian Hock, DE ...